Incidental prostate cancer (iPCa) has long been observed in tissue resected for benign prostatic hyperplasia (BPH), with prostate-specific antigen (PSA)-era TURP (transurethral resection of the prostate) series reporting lower detection rates than earlier eras [1,2]. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.